Vapotherm Inc (NYSE:VAPO) Director Anthony L. Arnerich bought 20,000 shares of the business’s stock in a transaction dated Wednesday, September 11th. The stock was bought at an average cost of $8.68 per share, for a total transaction of $173,600.00.

NYSE VAPO opened at $9.80 on Thursday. Vapotherm Inc has a 12 month low of $8.30 and a 12 month high of $24.63. The stock has a market cap of $158.54 million and a P/E ratio of -0.71. The stock’s fifty day moving average price is $12.60 and its 200-day moving average price is $17.46. The company has a current ratio of 5.22, a quick ratio of 4.34 and a debt-to-equity ratio of 1.42.

Vapotherm (NYSE:VAPO) last released its earnings results on Monday, July 29th. The company reported ($0.76) EPS for the quarter, topping analysts’ consensus estimates of ($0.81) by $0.05. The company had revenue of $11.99 million during the quarter, compared to analysts’ expectations of $11.90 million. As a group, analysts forecast that Vapotherm Inc will post -3.07 earnings per share for the current fiscal year.

Separately, Zacks Investment Research raised Vapotherm from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research note on Friday, August 2nd. Five investment analysts have rated the stock with a buy rating, The stock presently has an average rating of “Buy” and a consensus price target of $23.67.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Perceptive Advisors LLC grew its stake in shares of Vapotherm by 12.7% in the second quarter. Perceptive Advisors LLC now owns 1,404,470 shares of the company’s stock worth $32,302,000 after acquiring an additional 158,155 shares during the last quarter. First Light Asset Management LLC lifted its holdings in shares of Vapotherm by 24.6% during the second quarter. First Light Asset Management LLC now owns 496,969 shares of the company’s stock valued at $11,430,000 after purchasing an additional 97,977 shares in the last quarter. Federated Investors Inc. PA lifted its holdings in shares of Vapotherm by 32.8% during the first quarter. Federated Investors Inc. PA now owns 398,435 shares of the company’s stock valued at $7,829,000 after purchasing an additional 98,435 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Vapotherm by 60.2% during the second quarter. Vanguard Group Inc. now owns 376,660 shares of the company’s stock valued at $8,663,000 after purchasing an additional 141,539 shares in the last quarter. Finally, BlackRock Inc. lifted its holdings in shares of Vapotherm by 24.7% during the second quarter. BlackRock Inc. now owns 292,171 shares of the company’s stock valued at $6,719,000 after purchasing an additional 57,950 shares in the last quarter. 50.85% of the stock is currently owned by hedge funds and other institutional investors.

Vapotherm Company Profile

Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.

Further Reading: What is the return on assets (ROA) ratio?

Insider Buying and Selling by Quarter for Vapotherm (NYSE:VAPO)

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.